RATIONALE: Hereditary angioedema (HAE) is an autosomal dominant disease caused by the lack of or a dysfunctional C1-inhibitor protein, affecting the skin, mucosal tissues of the upper respiratory tract and gastrointestinal (GI)tract. Trauma, infections, stress, and drugs such as estrogen-containing medications, and angiotensin-converting enzyme inhibitors are known triggers. Heroin use precipitating attacks has never been reported. Herein, we report the cases of identical twins with angioedema leading to respiratory failure after heroin use. METHODS: Single-center retrospective observational case series RESULTS: 55-year-old female twins with confirmed HAE since childhood presented one week apart with severe angioedema attack both precipitated immediately following abuse of heroin. Urine toxicology screen was positive for heroin. The first sister presented to the emergency department (ED) with angioedema flare of her upper airway. Her course was uncomplicated as she already had tracheostomy placement from previous attack and her flare rapidly resolved after C1 esterase replacement therapy. One week later, her twin sister presented to the ED with similar symptoms immediately after heroin use and she required mechanical ventilatory support. Her flare also resolved post administration of C1 esterase. Both were released from the hospital improved. CONCLUSIONS: These 2 patients are the first reported cases of angioedema attacks resulting from heroin abuse and illustrate management challenges. HAE is known for painful flares involving the GI tract, which can often predispose patients to narcotic dependence for pain relief. In addition to medications, long-term management of HAE is avoiding the triggers. More research needs to be done regarding illicit drug abuse HAE attacks. 1 Hungarian Angioedema Reference Center, Third Department of Internal Medicine, Semmelweis University, Budapest, Hungary, Budapest, Hungary, 2 Department of Biomedical and Clinical Sciences, ASST Fatebenefratelli-Sacco, University of Milan, Luigi Sacco Hospital, Milan, Italy. RATIONALE: Hereditary angioedema (HAE) is a rare disease; its characterization requires safe and long-term storage of clinical and laboratory data accumulated from the patients. This is the purpose and function of the Global HAE Registry (GHR) established in the GHRConference. The GHR operates along corporate bylaws and protocols defined by HAE experts and IT professionals (Cloud-R). METHODS: Joining the GHR is a multi-step process. Candidates file a membership application with the Global HAE Registry Board, and attend a kick-off web seminar. Then, the protocol is submitted to and approved by the Ethics Committee. The Letter of Appointment of the Data Processor is countersigned by the Data Controller of the collaborating center. A collection of signed, original copies of informed consent should also be submitted. A training delivered by Cloud-R and the GHR Project manager should be completed. Finally, 10 valid clinical report forms (complete with laboratory findings confirming the diagnosis), and an outpatient record of a follow-up visit should be presented. RESULTS: Having fulfilled all the requirements, the Hungarian Angioedema Reference Center -with a 30-year history and responsible for the follow-up of 181 patients -joined among the first to the GHR. CONCLUSIONS: By joining the GHR, our center contributes to the database. The analysis of data from a large number of patients will lead to more accurate understanding of the disease. Further, it will allow for improving the treatment protocols in consideration of interindividual differences in therapeutic response. Finally, the GHR is a reliable source of high-quality information for research. CSL Behring, King of Prussia, PA. RATIONALE: The negative impact of hereditary angioedema (HAE) on patients' quality of life is well documented. The unpredictability of attacks and fear of asphyxiation contribute to anxiety even among diagnosed patients who have access to HAE-specific on-demand medications. In this exploratory survey-based study, we sought to determine whether anxiety surrounding HAE attacks leads to delays in seeking routine, preventive, or necessary health care. METHODS: We developed a brief questionnaire to assess whether patients with HAE delay recommended health procedures (eg, mammograms, dental work, cardiac tests) due to fear of an HAE attack. Questionnaires were sent via email to all patients on a patient advisory board. Responses were discussed in detail during follow-up group telephone interviews. RESULTS: Seven of 9 patients responded to the questionnaire; all respondents were female (mean age: 45 years) with an average of 4.4 attacks per month (range: 1 to 10) in the absence of prophylaxis. Four respondents (57%) reported delaying or avoiding routine health care procedures due to fear of an attack. Dental work (including dental surgery) was the most common type of health procedure delayed/avoideddrespondents noted that fear of a laryngeal attack leading to asphyxiation was the primary reason for delaying health procedures. Three of these 4 patients reported experiencing attacks of varying severity during routine health procedures. CONCLUSIONS: Although preliminary and observational, the results suggest that a substantial proportion of HAE patients may delay dental work or other procedures that might trigger a laryngeal attack due to fear of asphyxiation. These findings warrant further study. 
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